Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Herbal milk booster tested in 160 new moms

NCT ID NCT06558071

Disease control Sponsor: Dexa Medica Group Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a supplement made from katuk leaves, torbangun leaves, and snakehead fish extract in 160 new mothers. For 15 days, half the moms took the supplement and half took a placebo. The main goal was to see if the supplement helped babies gain more weight, which would mean the moms were making enough breast milk. The study is complete, but results are not yet reported.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

160 people

The number who actually took part.

Started

Oct 2024

Finished

May 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Signed informed consent prior to participation in the study. 2. Generally healthy women aged \>= 18-35 years. 3. Having a full-term gestational age (37- 40 weeks, inclusive). 4. The infant to breastfed: having normal birth body weight (2500-4000 gr). 5. Giving consent and commitment to pursue an exclusive breastfeeding 6. Willing to comply with the study protocol. 7. Spontaneous delivery. 8. Healthy newborn baby Exclusion Criteria: 1. Difficult breastfeeding due to organic defect; 2. Suspected COVID-19 by clinical symptoms. 3. LATCH Score \< 4; 4. Choosing not to breastfeed due to other subjective or objective reasons; 5. Having multiple birth; 6. Known major medical complications during delivery; 7. Known to have breast diseases, such as: mastitis, or malignancies 8. Breastfeeding prohibited due to clindamycin injection within the past week. 9. History of smoking, alcohol drinking, or any drug abuse 10. Known to have any relevant chronic infections or illness and gestational diabetes; 11. Known to have disorders of major organs ; 12. Taking any medication or supplementation known to have galactagogue properties within the last trimester of pregnancy; 13. Taking any non-pharmacological complementary treatment within the last trimester of pregnancy aiming to affect breast milk production. 14. Participation in any other interventional clinical studies within 30 days prior to Screening.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lactation induced are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lactation disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lactation induced

Contacts and locations

Locations

  • Klinik Pratama Anugrah Sleman

    Sleman, Special Region of Yogyakarta, Indonesia

  • Private Midwife Practice (Bidan Anisa)

    Sleman, Special Region of Yogyakarta, Indonesia

  • Private Midwife Practice (Bidan Catur)

    Sleman, Special Region of Yogyakarta, Indonesia

  • Private Midwife Practice (Bidan Istri Utami)

    Sleman, Special Region of Yogyakarta, Indonesia

  • Private Midwife Practice (Bidan Istri Yuliani)

    Sleman, Special Region of Yogyakarta, Indonesia

  • Private Midwife Practice (Bidan Kisti)

    Sleman, Special Region of Yogyakarta, Indonesia

  • Private Midwife Practice (Bidan Mei)

    Sleman, Special Region of Yogyakarta, Indonesia

  • Private Midwife Practice (Bidan Tutik)

    Sleman, Special Region of Yogyakarta, Indonesia

  • Private Midwife Practice (Bidan Wati)

    Sleman, Special Region of Yogyakarta, Indonesia

  • Private Midwife Practice (Bidan Widya)

    Sleman, Special Region of Yogyakarta, Indonesia